DOD-CDMRP: Prostate Cancer Research Program - Idea Development Award

Supports new ideas that represent innovative, high-risk/high-gain approaches to PC research.  Preliminary data are encouraged but not required. Emphasis is on Innovation and Impact. Clinical trials are not  allowed. Funding: $375K over 3 years. New Investigator Option: $225K over 3 years.

All applications for PCRP funding opportunities should also address at least one of 6 PCRP focus areas:
 - Biomarkers: Discovery and validation of biomarkers for the detection, prediction of response to therapy, prognosis,  and progression of PC.
 - Genetics: Understanding the genetics and epigenetics responsible for susceptibility, disease progression, and  treatment outcomes for clinically significant PC.
 - Imaging: Development of new anatomic and molecular imaging technology for the detection and management of PC.
 - Survivorship: Studies on the impact of treatment, nutrition, metabolism, and exercise on the well-being of PC patients and their families.
 - Therapy: Identification of new targets, pathways, and therapeutic modalities, including immunotherapy and mechanisms of resistance.
 - Tumor Biology and Immunology: Understanding prognosis and progression of PC.

Each PCRP funding opportunity either requires or encourages applications to address one of the following PCRPoverarching challenges:
- Develop effective treatments for advanced PC (i.e. disease relapse with no available curative therapy);
- Distinguish aggressive from indolent disease.